Vig Pamela

Average Profitability
53.04%
Insider Buys Quantity
1
Insider Buys Sum
$35,363.52
Insider Sells Quantity
6
Insider Sells Sum
$1.23M

Insider Activity of Vig Pamela

According to the SEC Form 4 filings, Vig Pamela, being in a position of

  1. CHIEF SCIENTIFIC OFFICER at Mirum Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 33181 share for $1.11M,
    over all time since 2019-09-06, has bought 3224 shares for $35,364, and sold 38713 shares for $1.23M.

The largest purchase of all time was on 2019-09-06 and amounted to 3224 shares of Mirum Pharmaceuticals, Inc. for $35,364.

The largest sale of all time was on 2024-06-24 and amounted to 30559 shares of Mirum Pharmaceuticals, Inc. for $1.04M.

Biography of Vig Pamela

No biography is available at this moment.

2024-06-24SaleMirum Pharmaceuticals, Inc.
MIRM
CHIEF SCIENTIFIC OFFICER
30,559
0.0633%
$34.00$1.04M+14.59%
2024-02-02SaleMirum Pharmaceuticals, Inc.
MIRM
CHIEF SCIENTIFIC OFFICER
1,214
0.0026%
$26.19$31,797+7.2%
2024-01-08SaleMirum Pharmaceuticals, Inc.
MIRM
HEAD OF RESEARCH & DEVELOPMENT
1,408
0.003%
$28.03$39,472-1.79%
2023-07-03SaleMirum Pharmaceuticals, Inc.
MIRM
Head of Research & Development
1,425
0.0038%
$25.65$36,546+5.32%
2023-01-09SaleMirum Pharmaceuticals, Inc.
MIRM
CHIEF SCIENTIFIC OFFICER
1,379
0.0038%
$20.62$28,438
2021-10-01SaleMirum Pharmaceuticals, Inc.
MIRM
Chief Scientific Officer
2,728
0.009%
$19.26$52,530+13.33%
2019-09-06PurchaseMirum Pharmaceuticals, Inc.
MIRM
Chief Scientific Officer
3,224
0.0181%
$10.97$35,364+53.04%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.